Physician

Robert D Allen, M.D.

According to 2025 Medicare claims, Robert Allen, M.D. (NPI: 1629074489) practices family practice in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is ADVENTIST HEALTH PHYSICIANS NETWORK (NPI: 1700592920; TIN: 68-0357690) and primary practice location at 93291-8222. Allen is affiliated with the Adventist Health Accountable Care, LLC (ACO ID: A3873) and Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Allen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,101 traditional Medicare patients, billed 74,482 HCPCS/CPT codes, and received $849,874 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 7,462 prescription claims across 635 beneficiaries totaling $473,181 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 500 claims. Open Payments data shows 2 records totaling $214. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $267,085 to $473,181. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $11,284 to $33,664.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	453	2,036	$107,517
2016	7,963	90,807	$1,144,946
2017	8,360	110,401	$1,354,298
2018	8,444	107,154	$1,314,894
2019	8,676	115,305	$1,292,908
2020	7,919	94,150	$954,241
2021	7,491	88,711	$919,741
2022	7,250	87,306	$896,999
2023	6,540	79,953	$885,477
2024	6,101	74,482	$849,874

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	429	4,594	$267,085
2016	451	5,409	$313,545
2017	430	5,312	$319,407
2018	457	5,418	$331,678
2019	515	6,198	$377,881
2020	530	6,875	$458,734
2021	573	7,196	$473,287
2022	585	7,589	$438,469
2023	615	7,430	$544,039
2024	635	7,462	$473,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	79	282	$7,844
2016	80	275	$5,884
2017	41	250	$4,775
2018	66	247	$4,113
2019	62	233	$9,287
2020	46	270	$12,618
2021	135	349	$13,281
2022	260	674	$26,910
2023	219	703	$36,863
2024	159	500	$31,368

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	3,312	4,417	$16
80061	Blood test, lipids (cholesterol and triglycerides)	4,065	5,666	$13
80053	Blood test, comprehensive group of blood chemicals	4,858	8,188	$10
36415	Insertion of needle into vein for collection of blood sample	5,837	13,877	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	4,803	8,124	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	59	3,750	$66,417
Ozempic	Semaglutide	39	1,450	$47,671
Eliquis	Apixaban	32	2,350	$45,324
Jardiance	Empagliflozin	46	2,035	$38,212
Myrbetriq	Mirabegron	23	930	$13,759

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	53	$18,194
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	25	$2,011
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	19	43	$1,904
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	19	$1,836
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	19	48	$1,769

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$214	Eko Health, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert D. Allen, M.D.?

Tedicare shows public-source Medicare data for Robert D. Allen, M.D. (NPI 1629074489), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert D. Allen, M.D. have ACO affiliation data?

Robert D. Allen, M.D. is shown with ACO affiliation data for Adventist Health Accountable Care, LLC (MSSP, ACO ID A3873) and Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Robert D. Allen, M.D.?

Robert D. Allen, M.D. is linked to ADVENTIST HEALTH PHYSICIANS NETWORK (billing NPI 1700592920) in the available physician profile data.

Does Robert D. Allen, M.D. have Open Payments data?

Robert D. Allen, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.